BVibe 9.94 mg/.1mL
Lidocaine HCL Delay Spray · LIQUID · COTR Inc
No Recall HistoryCurrently in Shortage
Plain English
BVibe is a liquid containing lidocaine hcl delay spray at 9.94 mg/.1mL, taken topical. Manufactured by COTR Inc.
Key Facts
- Brand Name
- BVibe
- Generic Name
- Lidocaine HCL Delay Spray
- NDC Code (Product)
85775-111- Manufacturer
- COTR Inc
- Strength
- 9.94 mg/.1mL
- Dosage Form
- LIQUID
- Route
- TOPICAL
- Marketing Status
- Application #
- M017
- Marketing Start
- 07/15/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is BVibe used for?
BVibe contains Lidocaine HCL Delay Spray. It is a liquid taken topical. Consult your doctor for specific uses.
Is BVibe a controlled substance?
BVibe is not classified as a controlled substance by the DEA.
What is the generic name for BVibe?
The generic name for BVibe is Lidocaine HCL Delay Spray. There are no other listed brand versions of Lidocaine HCL Delay Spray.
What is the NDC code for BVibe 9.94 mg/.1mL?
The NDC (National Drug Code) for BVibe 9.94 mg/.1mL is 85775-111, listed by COTR Inc.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)